Modulation of nuclear factor-κB activity can influence the susceptibility to systemic lupus erythematosus
Modulation of nuclear factor-κB activity can influence the susceptibility to systemic lupus erythematosus
复制标题
DOI:
10.1111/j.1365-2567.2008.02964.x
复制
发表时间:
2009-09-01
期刊:
影响因子:
6.4
通讯作者:
Jacobelli, Sergio H.
中科院分区:
文献类型:
--
作者:
Kalergis, Alexis M.;Iruretagoyena, Mirentxu I.;Jacobelli, Sergio H.
P>Autoimmune diseases, such as systemic lupus erythematosus (SLE), result from deficiencies in self-antigen tolerance processes, which require regulated dendritic cell (DC) function. In this study we evaluated the phenotype of DCs during the onset of SLE in a mouse model, in which deletion of the inhibitory receptor Fc gamma RIIb leads to the production of anti-nuclear antibodies and glomerulonephritis. Splenic DCs from Fc gamma RIIb-deficient mice suffering from SLE showed increased expression of co-stimulatory molecules. Furthermore, diseased mice showed an altered function of the nuclear factor-kappa B (NF-kappa B) transcription factor, which is involved in DC maturation. Compared with healthy animals, expression of the inhibitory molecule I kappa B-alpha was significantly decreased in mice suffering from SLE. Consistently, pharmacological inhibition of NF-kappa B activity in Fc gamma RIIb-deficient mice led to reduced susceptibility to SLE and prevented symptoms, such as anti-nuclear antibodies and kidney damage. Our data suggest that the occurrence of SLE is significantly influenced by alterations of NF-kappa B function, which can be considered as a new therapeutic target for this disease.